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background:  GlycA is a novel nuclear magnetic resonance (NMR) spectroscopy signal in plasma arising from the glycosylation of 
circulating acute phase proteins. GlycA has been independently associated with overt coronary heart disease (CHD), but the incidence of 
cardiovascular disease (CVD) in subjects free of overt CVD has not been studied. We examined the association and predictive value of 
GlycA, high sensitive C-reactive protein (hs-CRP) and interleukin6 (IL-6) with incident CVD in asymptomatic middle age and older subjects 
in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort.
Methods:  6491 men and women (white, black, Hispanic and Chinese), age range 45-84 years, who had a fasting venous blood sample for 
measurement of lipid profile, lipoprotein particles using NMR, IL-6, hs-CRP and D-dimer at MESA baseline. The median follow-up was 10.1 
years. Adjudicated CVD events were defined as CHD: myocardial infarction, coronary artery disease, coronary revascularization, angina; 
atherosclerotic non-CHD: stroke, peripheral artery disease; heart failure (HF) and CVD death. We performed Poisson regression incidence 
density (over a median of 10.1 years) for fatal and nonfatal CVD to estimate outcome associations with GlycA in a model adjusted for 
age, race, gender, site, height, heart rate, blood pressure, BMI, smoking history, diabetes, lipids, low estimated glomerular filtration rate, 
lipoprotein particle concentrations, IL-6 and hsCRP.
Results:  At baseline median GlycA (interquartile range) was 328 (294, 367) µmol/L. GlycA was positively related to incident CVD (762 
cases); hazard ratio (95% CI) per SD (54 µmol/L), 1.13 (1.03-1.23), P = 0.01. It also predicted hard CHD (269 cases from myocardial 
infarction or CHD death); HR 1.29 (1.12-1.50), P = 0.0006. Stroke and heart failure were not significantly related to GlycA.
conclusion:  Higher levels of Glyc A are associated with increased risk of CVD and especially CHD after considering established CVD risk 
factors, hs-CRP, IL-6 and D-dimer in asymptomatic subjects free of overt CVD.
